Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel T Welch

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biologicals : Journal of the International Association of Biological Standardization|October 8, 2019
Considering "clonality": A regulatory perspective on the importance of the clonal derivation of mammalian cell banks in biopharmaceutical developmentJoel T Welch, N Sarah Arden
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2003
Lanthanide-binding helix-turn-helix peptides: solution structure of a designed metallonucleaseJoel T Welch, William R Kearney, Sonya J Franklin
Journal of the American Chemical Society|May 29, 2003
Sequence-selective DNA cleavage by a chimeric metallopeptideRoger T Kovacic, Joel T Welch, Sonya J Franklin
Chemical Communications (Cambridge, England)|November 5, 2003
Gadolinium-binding helix-turn-helix peptides: DNA-dependent MRI contrast agentsPeter Caravan, Jaclyn M Greenwood, Joel T Welch, et al.
Inorganic Chemistry|November 25, 2003
Europium luminescence of EF-hand helix-turn-helix chimeras: impact of pH and DNA-binding on europium coordinationSandhya Jain, Joel T Welch, William D Horrocks, et al.
Investigative Radiology|September 3, 2010
High relaxivity magnetic resonance imaging contrast agents. Part 1. Impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexesStéphane Dumas, Vincent Jacques, Wei-Chuan Sun, et al.
Frontiers in Bioengineering and Biotechnology|June 20, 2019
Cyberbiosecurity for Biopharmaceutical ProductsJennifer L Mantle, Jayan Rammohan, Eugenia F Romantseva, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biologicals : Journal of the International Association of Biological Standardization|October 8, 2019
Considering "clonality": A regulatory perspective on the importance of the clonal derivation of mammalian cell banks in biopharmaceutical developmentJoel T Welch, N Sarah Arden
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2003
Lanthanide-binding helix-turn-helix peptides: solution structure of a designed metallonucleaseJoel T Welch, William R Kearney, Sonya J Franklin
Journal of the American Chemical Society|May 29, 2003
Sequence-selective DNA cleavage by a chimeric metallopeptideRoger T Kovacic, Joel T Welch, Sonya J Franklin
Chemical Communications (Cambridge, England)|November 5, 2003
Gadolinium-binding helix-turn-helix peptides: DNA-dependent MRI contrast agentsPeter Caravan, Jaclyn M Greenwood, Joel T Welch, et al.
Inorganic Chemistry|November 25, 2003
Europium luminescence of EF-hand helix-turn-helix chimeras: impact of pH and DNA-binding on europium coordinationSandhya Jain, Joel T Welch, William D Horrocks, et al.
Investigative Radiology|September 3, 2010
High relaxivity magnetic resonance imaging contrast agents. Part 1. Impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexesStéphane Dumas, Vincent Jacques, Wei-Chuan Sun, et al.
Frontiers in Bioengineering and Biotechnology|June 20, 2019
Cyberbiosecurity for Biopharmaceutical ProductsJennifer L Mantle, Jayan Rammohan, Eugenia F Romantseva, et al.
Pageof 1